ternspharma.com - Volume dana dhuwit perusahaan TERN

Simbol resmi perusahaan Terns Pharmaceuticals, Inc. (TERN)

Terns Pharmaceuticals (TERN) possesses significant pricing potential due to the development of safe oral inhibitors. The expansion of metabolic disorder therapy markets opens colossal sales prospects. The size of the cash reserve demonstrates financial stability, while the 1.00 metric serves as the target level. The development strategy relies on international scientific collaborations to identify cutting-edge treatments for liver pathologies.

TERN - Volume dana dhuwit perusahaan Terns Pharmaceuticals Inc ing rentang 04.07.2022 - 16.05.2026

Rincian metrik lan analitis perusahaan Terns Pharmaceuticals, Inc. (TERN)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:ternspharma.com
Produk mawa merek ternspharma.com

This indicator measures the volume of liquid assets, allowing for an assessment of the issuer's solvency and its ability to service obligations without incurring external debt. By analyzing the company's cash position, an investor distinguishes market noise from financial stability, which is critical for Terns Pharmaceuticals (TERN) in securing costly biosample logistics and ensuring the uninterrupted conduct of clinical drug trials.